- CEO
- Yi-Kuan Lin
- Full Time Employees
- 180
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 17 Hanover Square Taipei TP Taiwan, Province of China W1S 1BN
- IPO Date
- Feb 2, 1995
- Business
- Plandaí Biotechnology, Inc. (PLPL) focuses on the production of proprietary botanical extracts for the nutraceutical and pharmaceutical industries; it develops and commercializes Phytofare Catechin Complex, a green tea-derived extract harvested from its Senteeko Tea Estate in Mpumalanga, South Africa, along with Phytofare citrus complex from citrus fruits, lycopene from tomatoes, extracts from Artemisia and cannabis, citrus bioflavonoids, limonoids, and Pheroid technology for entrapped delivery of these extracts; the company also produces and sells timber and agricultural products from its South African farm and tea estate holdings. Incorporated in Nevada in 2004 and headquartered in London, United Kingdom, with principal operations in South Africa under a 50-year lease on a 3,000-hectare estate, Plandaí Biotechnology serves global markets in health, wellness, and pharmaceutical sectors through its subsidiaries. In 2023, the company entered into a share exchange agreement to acquire Good Salt, LLC, incorporating assets of ByoPlanet International and Clean Republic for electrostatic disinfection technology focused on health innovation in animal health, commercial cleaning, and public services, with plans to rebrand as ByoPlanet, Inc., though the agreement was later rescinded due to failure of consideration; it completed audits for fiscal years 2021 and 2022 in preparation for potential uplisting.